Renata (DHA:RENATA) Change In Receivables : BDT192 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Renata Change In Receivables?

Renata's change in receivables for the quarter that ended in Mar. 2024 was BDT426 Mil. It means Renata's Accounts Receivable declined by BDT426 Mil from Dec. 2023 to Mar. 2024 .

Renata's change in receivables for the fiscal year that ended in Jun. 2023 was BDT-200 Mil. It means Renata's Accounts Receivable increased by BDT200 Mil from Jun. 2022 to Jun. 2023 .

Renata's Accounts Receivable for the quarter that ended in Mar. 2024 was BDT3,560 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Renata's Days Sales Outstanding for the three months ended in Mar. 2024 was 35.21.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Renata's liquidation value for the three months ended in Mar. 2024 was BDT-11,226 Mil.

Renata Change In Receivables Historical Data

The historical data trend for Renata's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renata Change In Receivables Chart

Renata Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Receivables

Get a 7-Day Free Trial

-182.86

-403.44

-542.03

-185.89

-200.23

Renata Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-347.85	361.67	-426.64	-168.75	426.02

Renata Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT192 Mil.

Renata (DHA:RENATA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Renata's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3559.994	/	9226.168	*	91
=	35.21

2. In Ben Graham's calculation of liquidation value, Renata's accounts receivable are only considered to be worth 75% of book value:

Renata's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1255.618	-	21826.381	+	0.75 * 3559.994	+	0.5 * 13349.288
=	-11,226

Renata Change In Receivables Related Terms

Thank you for viewing the detailed overview of Renata's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Renata Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216

Website

https://www.renata-ltd.com

Renata Ltd is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.

Renata Headlines

No Headlines